The global artificial vital organs and medical bionics market size was valued at USD 45.0 billion in 2025 and is projected to grow from USD 49.2 billion in 2026 to USD 91.7 billion in 2033, at a CAGR of 9.3% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 44.5% in 2025. Market growth has been driven by several factors, including technological advancements, the rising incidence of disorders, and an aging population. Moreover, increased investment in research and development, as well as the growing number of patients waiting for organ transplants, have contributed to the market’s growth. Furthermore, government efforts to ensure patient safety have also stimulated market growth.
Market growth worldwide is driven by a confluence of demographic shifts and technological advancements. The increasing number of individuals over the age of 65, who are more susceptible to organ failure, is a major factor driving demand for organ implants and artificial vital organs. According to the Directorate General of Health Services, India alone has over 1.8 lakh people suffering from renal failure, with only 60,000 receiving transplants, while over 2 lakh people suffer from liver failure or cancer, with only 1,500 transplants performed. As the global population ages, the need for effective solutions to address organ failure has become more pressing, creating opportunities for market players to develop innovative products.
Continuous technological breakthroughs in medical research and biomedical engineering are also contributing to market expansion. The shortage of donor organs for transplantation, which results in lengthy waiting times and limited availability of suitable donors, has created a high demand for artificial vital organs. Furthermore, the rising prevalence of chronic diseases, such as heart disease, diabetes, and kidney disease, which often result in organ failure, is another significant factor contributing to market growth.
Growing healthcare expenditure, particularly in emerging economies, is another driver for market growth. As patients seek to improve their quality of life and extend their lifespan, the adoption of artificial vital organs and medical bionics is increasing. Moreover, positive government actions to protect patient safety standards and research activities, as well as increased awareness of public and private reimbursement coverage, are boosting adoption rates and creating opportunities for market players.
▪ Canada
▪ Mexico
▪ Germany
▪ France
▪ Italy
▪ Spain
▪ Denmark
▪ Sweden
▪ Norway
▪ China
▪ India
▪ Australia
▪ South Korea
▪ Thailand
▪ Argentina
▪ Saudi Arabia
▪ UAE
▪ Kuwait
This product will be delivered within 1-3 business days.
Market growth worldwide is driven by a confluence of demographic shifts and technological advancements. The increasing number of individuals over the age of 65, who are more susceptible to organ failure, is a major factor driving demand for organ implants and artificial vital organs. According to the Directorate General of Health Services, India alone has over 1.8 lakh people suffering from renal failure, with only 60,000 receiving transplants, while over 2 lakh people suffer from liver failure or cancer, with only 1,500 transplants performed. As the global population ages, the need for effective solutions to address organ failure has become more pressing, creating opportunities for market players to develop innovative products.
Continuous technological breakthroughs in medical research and biomedical engineering are also contributing to market expansion. The shortage of donor organs for transplantation, which results in lengthy waiting times and limited availability of suitable donors, has created a high demand for artificial vital organs. Furthermore, the rising prevalence of chronic diseases, such as heart disease, diabetes, and kidney disease, which often result in organ failure, is another significant factor contributing to market growth.
Growing healthcare expenditure, particularly in emerging economies, is another driver for market growth. As patients seek to improve their quality of life and extend their lifespan, the adoption of artificial vital organs and medical bionics is increasing. Moreover, positive government actions to protect patient safety standards and research activities, as well as increased awareness of public and private reimbursement coverage, are boosting adoption rates and creating opportunities for market players.
Global Artificial Vital Organs and Medical Bionics Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global artificial vital organs and medical bionics market report based on artificial organs, bionics, and region:Artificial Organs Outlook (Revenue, USD Billion, 2021 - 2033)
- Heart
- Kidney
- Liver
- Pancreas
- Lungs
Bionics Outlook (Revenue, USD Billion, 2021 - 2033)
- Ear Bionics
- Vision Bionics
- Exoskeletons
- Bionic Limbs
- Brain Bionics
- Cardiac Bionics
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
▪ Canada
▪ Mexico
- Europe
▪ Germany
▪ France
▪ Italy
▪ Spain
▪ Denmark
▪ Sweden
▪ Norway
- Asia Pacific
▪ China
▪ India
▪ Australia
▪ South Korea
▪ Thailand
- Latin America
▪ Argentina
- Middle East & Africa
▪ Saudi Arabia
▪ UAE
▪ Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Artificial Vital Organs and Medical Bionics Market Variables, Trends, & Scope
Chapter 4. Artificial Vital Organs and Medical Bionics Market: Artificial Organ Estimates & Trend Analysis
Chapter 5. Artificial Vital Organs and Medical Bionics Market: Bionics Estimates & Trend Analysis
Chapter 6. Artificial Vital Organs and Medical Bionics Market: Regional Estimates & Trend Analysis
Chapter 7. Competitive Landscape
Companies Mentioned
- Medtronic, Inc.
- LifeNet Health
- Terumo Corporation
- Ekso Bionics Holdings, Inc.
- Nano Retina Ltd.
- Edwards Lifesciences Corporation
- InnoScot Health Ltd.
- Ottobock SE & Co. KGaA
- Orthofix Medical Inc.
